FitLife Brands, Inc. (FTLF) income statement
FTLFNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/303% below fair value
$6.70−0.19 (-2.76%)
Close on Nov 19, 2026Market cap $62.92MP/E 35.3Yield –
FitLife Brands, Inc. financial ratios
See a number that looks wrong?